ischemia-modified albumin

06/01/2012 - "Perioperative serum ischemia-modified albumin levels might be helpful in predicting perioperative myocardial infarction."
07/01/2009 - "To assess the value of an improved ischemia modified albumin (IMA) assay in the diagnosis of early acute myocardial infarction (AMI). "
07/01/2009 - "[Clinical value of an improved ischemia-modified albumin assay in the diagnosis of early acute myocardial infarction]."
03/01/2016 - "Ischemia modified albumin (IMA) has emerged as a marker for ischemic injury and oxidative damage, particularly in myocardial infarction. "
03/01/2013 - "Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction."

01/01/2017 - "The studies have shown that ischemia-modified albumin (IMA), which has widely been studied as a marker of ischemia, also increases as result of oxidative stress. "
05/01/2011 - "Ischemia-modified albumin (IMA) is an ischemia marker, which has recently been investigated in many studies and largely validated for early detection of ischemia. "
03/01/2021 - "Ischemia-modified albumin (IMA) is a novel marker for the detection of ischemia. "
08/01/2020 - "Ischemia-modified albumin (IMA) levels may have a predictive role in the identification and prevention of hypoxic disorders, as they increase in cases of ischemia of the liver, heart, brain, bowel, and kidney. "
01/01/2017 - "Ischemia-modified albumin (IMA) was recognized as a novel marker of oxidative stress and ischemia. "

08/01/2015 - "Ischemia-modified albumin levels in overt and subclinical hypothyroidism."
03/01/2014 - "Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism."
09/01/2012 - "Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism."
04/01/2015 - "Aim of our present study was to evaluate any potential role of ischemia modified albumin (IMA) in both sub clinical and established hypothyroidism and to explore its potential relationship with the hsCRP. "
04/01/2015 - "Effect of Sub Clinical Hypothyroidism on C-reactive Protein and Ischemia Modified Albumin."

01/01/2023 - "Logistic regression analysis revealed that a one-unit increase in Ischemia Modified Albumin resulted in a statistically significant 1.9-fold increase in the risk of Severe hyperemesis gravidarum (OR 1.92, 95% CI 1.008-1.956; P = 0.01) CONCLUSION: This study shows that there is a condition in the pathophysiology of hyperemesis gravidarum, with an increase in Ischemia Modified Albumin and a decrease in Total-Sulphydryl levels, and oxidative stress occurs. "
01/01/2023 - "This study investigates the relationship between Ischemia Modified Albumin and Total-Sulphydryl levels with some subclinical inflammatory markers in patients with hyperemesis gravidarum. "
01/01/2023 - "Among the subgroups, the highest Ischemia Modified Albumin value was observed in the severe hyperemesis gravidarum group, and the highest Total-Sulphydryl level was observed in the mild hyperemesis gravidarum group (P < 0.001). "
01/01/2023 - "Maternal serum ischemia-modified albumin (IMA), total-sulphydryl concentrations, and some subclinic inflammatory markers in hyperemesis gravidarum (HG)."
05/24/2017 - "Our objective was to measure the circulating levels of ischemia-modified albumin (IMA) among pregnant with hyperemesis gravidarum (HEG) and to compare their levels with age- and body mass index (BMI)-matched control pregnant women. "

10/15/2023 - "However, no study was evaluated in which the change in thiol-disulphide homeostasis, ischemia-modified albumin (IMA), complete blood count-derived inflammatory markers (CBC-IMs) and C-reactive protein (CRP) levels in bipolar patients was followed-up from acute mania to early remission. "
10/15/2023 - "Thiol-disulphide homeostasis, ischemia-modified albumin, complete blood count-derived inflammatory markers and C-reactive protein from acute mania to early remission in bipolar disorder."